These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3542644)

  • 21. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study.
    King H; Zimmet P; Raper LR; Balkau B
    Diabetologia; 1984 Jan; 26(1):39-43. PubMed ID: 6706044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
    Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
    Panarotto D; Ardilouze JL; Tessier D; Maheux P
    Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for NIDDM in white population. Paris prospective study.
    Charles MA; Fontbonne A; Thibult N; Warnet JM; Rosselin GE; Eschwege E
    Diabetes; 1991 Jul; 40(7):796-9. PubMed ID: 2060716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic.
    Warram JH; Sigal RJ; Martin BC; Krolewski AS; Soeldner JS
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S40-5. PubMed ID: 8894480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight change amongst Nauruans over 6.5 years: extent, and association with glucose intolerance.
    Sicree RA; Zimmet PZ; King H; Coventry JS
    Diabetes Res Clin Pract; 1987; 3(6):327-36. PubMed ID: 3665732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
    Weyer C; Tataranni PA; Bogardus C; Pratley RE
    Diabetes Care; 2001 Jan; 24(1):89-94. PubMed ID: 11194248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.
    Wolever TM; Chiasson JL; Csima A; Hunt JA; Palmason C; Ross SA; Ryan EA
    Diabetes Care; 1998 Mar; 21(3):336-40. PubMed ID: 9540012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women.
    Buchanan TA; Xiang A; Kjos SL; Lee WP; Trigo E; Nader I; Bergner EA; Palmer JP; Peters RK
    Diabetes; 1998 Aug; 47(8):1302-10. PubMed ID: 9703332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
    Shaw JE; Zimmet PZ; de Courten M; Dowse GK; Chitson P; Gareeboo H; Hemraj F; Fareed D; Tuomilehto J; Alberti KG
    Diabetes Care; 1999 Mar; 22(3):399-402. PubMed ID: 10097917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between prevalence of impaired glucose tolerance and NIDDM in a population.
    Dowse GK; Zimmet PZ; King H
    Diabetes Care; 1991 Nov; 14(11):968-74. PubMed ID: 1797510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
    Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
    Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes.
    Mykkänen L; Laakso M; Uusitupa M; Pyörälä K
    Diabetes Care; 1990 Nov; 13(11):1099-105. PubMed ID: 2261821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
    Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
    Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.